drugset / Trial / NCT00539786

The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

NCT00539786

Unknown 100 enrolled Samsung Medical Center
Parallel-groupOpen-labelDiagnostic

Summary

PPI test;empirical trial with high-dose proton-pump inhibitors (PPIs) has been shown to be a sensitive tool for diagnosing patients with GERD. However, this diagnostic strategy has not been well established in patients with extraesophageal manifestation of GERD. In this study, we aim to see the relevance of PPI test in diagnosing GERD in patients with extraesophageal symptoms.

Timeline

Start
2006-03
Primary completion
2011-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg